G0S2 downregulation in CML was not a result of promoter hypermethylation or BCR::ABL1 kinase activity, but was rather due to transcriptional repression by MYC. The gene discussed is MYC; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.